Team:Cornell/testing/notebook/wetlab/5

From 2012.igem.org

(Difference between revisions)
 
(3 intermediate revisions not shown)
Line 51: Line 51:
<div class="row">
<div class="row">
<div class="nine columns">
<div class="nine columns">
-
<h3>Bootcamp Overview</h3>
+
<h3>Wrap Up</h3>
-
From June 12th-22nd, the DeLisa lab kindly hosted a synthetic biology ‘bootcamp’ for our team members. Dr. Didi Waraho assisted in the instruction of new team members, while Taylor Stevenson helped more experienced members get acquainted with the Gibson assembly method.
+
<p>We have successfully created working arsenic and salicylate sensing constructs and have shown that they are functional in <em>Shewanella</em> and  are continuing to characterization of our arsenic and salicylate constructs. Although the response in our reactors is not as sensitive as we would hope, we have various hypotheses that we hope to test. Furthermore, we are using RT-qPCR, western blots, and fluorescence measurements to quantify transcription and translation of mtrB levels in response to varying concentrations of arsenic and salicylate. We also plan on running time courses to determine when mtrB is expressed in the presence of analyte.</p>
-
<br><br>
+
 
-
Didi’s group worked on the construction of our arsenic reporter plasmids (now referred to as p14k and p16k). This work involved PCR steps to append non-BioBrick cutsites (AscI and BamHI) to an existing </i>mtr</i>B BioBrick (BBa_K098994) and an arsenic-sensing region (BBa_J33201) in order to introduce modularity for easy promoter switching. By the end of the bootcamp, we confirmed via Sanger sequencing that both versions of our arsenic reporter had been successfully cloned into DH5a, electrocompotent <i>E. coli</i> cells. The next step would be to get the plasmids into our <i>Shewanella</i> strain lacking <i>mtr</i>B on the chromosome (JG700).
+
<p>We are still continuing work on the nah operon. By using site-directed mutagenesis, we aim to make our nah part BioBrick compatible, and we still need to confirm successful conjugation of nah into our <em>Shewanella</em> strains.</p>
-
<br><br>
+
-
Taylor’s group had one goal: To get internal PstI and NotI cutsites out of our 10kb naphthalene-degrading (nah) operon while constructing the final plasmid to be transformed into <i>Shewanella</i>. By using mutagenic PCR primers that would introduce silent mutations to get rid of the non-BioBrick compatible internal cutsites, the group planned on ripping the nah operon apart, so to speak, and putting it back together again and into a pBMT-1 backbone via Gibson assembly. Using the NAH7 plasmid (containing nah operon) from<i>Pseudomonas putida</i> G7 (kindly provided by Dr. Gene Madsen), Taylor’s group completed all PCR steps necessary for Gibson assembly, incubated the PCR products with Gibson master mix, and transformed the Gibson products into DH5a&#8212;yielding three transformants. At the end of bootcamp, the group ran supercoiled plasmid (miniprepped from transformants) on a gel&#8212;as an initial screen for successful construction of our naphthalene-degrading plasmid. As shown below, the gel showed distinct bands for all three lanes. However, further confirmation was necessary, so the next step was to digest the Gibson products to check for correct fragment lengths, and to submit DNA for Sanger sequencing.  
+
</div>
</div>
<div class="three columns">
<div class="three columns">
-
<img src="http://placehold.it/250x250/321852">
+
</div>
</div>
-
<div class="twelve columns"> <img class="inline" src="https://static.igem.org/mediawiki/2012/a/a1/Cornell2012_0621_Gibson-entire-plasmid.jpg"> </div>
+
 

Latest revision as of 03:58, 4 October 2012

Wet Lab Notebook – Wrap Up

  • Wrap Up

    We have successfully created working arsenic and salicylate sensing constructs and have shown that they are functional in Shewanella and are continuing to characterization of our arsenic and salicylate constructs. Although the response in our reactors is not as sensitive as we would hope, we have various hypotheses that we hope to test. Furthermore, we are using RT-qPCR, western blots, and fluorescence measurements to quantify transcription and translation of mtrB levels in response to varying concentrations of arsenic and salicylate. We also plan on running time courses to determine when mtrB is expressed in the presence of analyte.

    We are still continuing work on the nah operon. By using site-directed mutagenesis, we aim to make our nah part BioBrick compatible, and we still need to confirm successful conjugation of nah into our Shewanella strains.

    • Retrieved from "http://2012.igem.org/Team:Cornell/testing/notebook/wetlab/5"